A recent Columbia University study showing detailed images of a molecule that transports Omega 3 fatty acids to the brain could open a pathway for neurological drugs to enter brain structures.
One of the main challenges in treating neurological diseases is getting drugs through the blood-brain barrier, a tightly packed layer of cells that lines blood vessels in the brain and blocks the entry of pathogens, toxins, and some nutrients. Unfortunately, this layer also blocks many drugs that could treat disorders of the neurological system.
- Scientists in Fear of This New Predator From Red Sea Eating Native Species in Mediterranean
- Does This Mean We Stopped Being Animal and Started Being Human Due to ‘Copy Paste’ Errors?
- The One Lifestyle Choice That Could Reduce Your Heart Disease Risk By More Than 22%
- Aging: This Is What Happens Inside Your Body Right After Exercise
- Immune-Boosting Drink that Mimics Fasting to Reduce Fat – Scientists ‘Were Surprised’ By New Findings
“We’ve managed to obtain a three-dimensional structure of the transporter protein that provides a gateway for omega-3s to enter the brain. In this structure, we can see how omega-3s bind to the transporter. This information may allow for the design of drugs that mimic omega-3s to hijack this system and get into the brain,” says one of the study’s authors, Dr. Rosemary J. Cater.
Essential nutrients, such as Omega 3s, require the help of specific carrier proteins that recognize them and make them pass through this barrier.
“The transporters are like bouncers at a club, only letting molecules with invites or backstage passes in,” explains Cater.
The transporter – or guard – a protein that allows Omega 3s to enter is called MFSD2A and is the focus of the research.
To visualize MFSD2A, the researcher used a technique called single-particle cryoelectron microscopy.
“The beauty of this technique is that we’re able to see the shape of the transporter with details down to a fraction of a billionth of a meter,” says study co-director Dr. Filippo Mancia.
For this analysis, the protein molecules are suspended in a thin layer of ice under an electron microscope. Powerful cameras take millions of images of proteins from countless angles can then be pieced together to build a 3D map.
From this map, the researchers can build a 3D model of the protein, placing each atom in its place.
“It reminds me of solving a jigsaw puzzle,,” explains Mancia.
This technique has become in recent years a very powerful tool for visualizing biological molecules.
“Our structure shows that MFSD2A has a bowl-like shape and that omega-3s bind to a specific side of this bowl,” explains Cater.
To understand what these movements might look like, a second co-director of the study, Dr. George Khelashvili, used a 3D model of the protein as a starting point for computer simulations that revealed how the transporter moves and how it adapts its shape to release the Omega 3 in the brain.
A third co-director of the project, Dr. David Silver, together with his team tested and confirmed the hypotheses derived from the explained structure and the simulations of the operation of the MFSD2A. That allowed him to highlight the specific parts of the protein that are important.
Now the team is investigating how the transporter first recognizes Omega 3s from the bloodstream.
- Scientists in Fear of This New Predator From Red Sea Eating Native Species in Mediterranean
- Does This Mean We Stopped Being Animal and Started Being Human Due to ‘Copy Paste’ Errors?
- The One Lifestyle Choice That Could Reduce Your Heart Disease Risk By More Than 22%
- Aging: This Is What Happens Inside Your Body Right After Exercise
- Immune-Boosting Drink that Mimics Fasting to Reduce Fat – Scientists ‘Were Surprised’ By New Findings
“Our study has already given us tremendous insight into how MFSD2A delivers omega-3s to the brain, and we are really excited to see where our results lead to,” says Cater.